Papers
4
Total Citations
148
H-Index
4
About
Professor Tanja Fehm is a leading figure in gynecologic oncology, with a research focus sharpened on the clinical behavior and optimal management of borderline ovarian tumors (BOT). Her major contributions stem from her pivotal role in the large-scale AGO ROBOT study, which has fundamentally shaped the understanding of this disease. Her work has demonstrated that age is a critical variable in BOT prognosis, revealing that younger patients often present with distinct clinical characteristics and outcomes. Furthermore, she has rigorously analyzed the prognostic impact of individual surgical staging procedures, providing evidence-based guidance for treatment. Her most cited paper, an analysis of age-dependent differences in BOT, has garnered 75 citations, underscoring its influence. Beyond BOT, Professor Fehm has contributed to the critical discourse on cervical cancer treatment, notably through her commentary on the landmark LACC trial. Her research, which also includes evaluating the diagnostic value of serum CA125, has been instrumental in refining surgical and diagnostic strategies, directly impacting patient care and establishing her as a key authority in her field.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary14 citations · 2015